Trial of anti-malarials to prevent coronavirus resumes
The UK trial of hydroxychloroquine and chloroquine was put on hold after another study found hydroxychloroquine had no benefit as a treatment
A global trial designed to test whether two anti-malaria drugs can prevent infection with COVID-19 is to restart after being approved by British regulators.
The trial was paused pending review after another UK trial found hydroxychloroquine had no benefit as a treatment in patients already infected with the virus .
